PS
ROIV icon

Principal Securities’s Roivant Sciences ROIV Stock Holding History

Principal Securities’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-203
Closed -$3.07K – 3074
2025
Q3 		$3.07K Hold
203
– – ﹤0.01% 3117
2025
Q2 		$2.29K Sell
203
-22
-10% -$238 ﹤0.01% 3103
2025
Q1 		$2.66K Hold
225
– – ﹤0.01% 2966
2024
Q4 		$2.66K Buy
225
+41
+22% +$485 ﹤0.01% 2961
2024
Q3 		$2.12K Buy
+184
New +$2.1K ﹤0.01% 2941

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Principal Securities's ROIV Position: Q4 2025 in Review

Principal Securities sold out of Roivant Sciences (ROIV) in Q4 2025, closing a stake of 203 shares — an estimated $3.07K sold.

Principal Securities first reported a position in ROIV in Q3 2024 and held it in 5 quarters. The position peaked at $3.07K in Q3 2025. 396 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • Principal Securities reported no remaining Roivant Sciences position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 203 Roivant Sciences shares in Q4 2025, an estimated $3.07K.
  • Principal Securities first reported a position in Roivant Sciences in Q3 2024 and held it in 5 quarters.
  • Principal Securities's Roivant Sciences position peaked at $3.07K in Q3 2025.
  • 396 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.